Prof. Feng Wang | Materials Science | Best Researcher Award

Professor at Southwest University, China

Feng Wang is a Professor at the Biological Research Center of Southwest University, China, specializing in molecular biology, genetic engineering, and biomaterials. He earned his Ph.D. in Biochemistry and Molecular Biology from Southwest University in 2014. Wang’s research focuses on genetic modification of silkworms to produce functional biomaterials and recombinant proteins for biomedical applications, such as tissue engineering and drug delivery. His work on genome editing using CRISPR/Cas9 and other techniques has led to significant advancements in bio-functional silk production. Wang has published extensively in high-impact journals, contributing to the fields of biotechnology and bioengineering. He has also held roles as a visiting scholar and postdoctoral researcher at various institutions. His groundbreaking research continues to make valuable contributions to the development of innovative medical technologies.

Professional Profile

• Scopus Profile
• ORCID Profile

Education and Work Experience:

Feng Wang completed his undergraduate degree in Bioengineering at the College of Life Science, Southwest University, Chongqing, China, graduating in 2008. He pursued advanced studies at the same institution, earning a Ph.D. in Biochemistry and Molecular Biology from the State Key Laboratory of Silkworm Genome Biology, Southwest University, in 2014. During his academic career, he has held several important positions. He became an Associate Professor at Southwest University in 2018, and in 2023, he was promoted to a full Professor at the Biological Research Center of the university. Wang has also gained valuable international experience as a visiting scholar at Tufts University, USA, from 2018 to 2019. Before this, he served as a research associate and postdoctoral researcher at Southwest University’s College of Biotechnology, contributing significantly to the fields of molecular biology and biotechnology. His career trajectory showcases his growing expertise and leadership in the scientific community, particularly in genetic engineering and biomaterial development, where he continues to make notable contributions to both academia and industry.

Research Interests and Contributions:

Feng Wang’s primary research interests focus on the genetic modification of silkworms and other insect species to enhance functional biomaterials. He specializes in genome editing techniques such as CRISPR/Cas9, TALEN, and ZFN to regulate gene expression and modify silkworm genomes for various applications. Wang has pioneered the use of genetically engineered silkworm spun silk as a potential biomaterial for biomedical purposes, including tissue engineering. His work on producing recombinant pharmaceutical proteins, such as growth factors, human lactoferrin, and human serum albumin, within silkworms, has significant implications for cost-effective, large-scale production of valuable biomolecules. Wang’s research also explores the use of silkworm silk glands as bioreactors for producing proteins with therapeutic applications. His recent studies emphasize the development of silk-based materials for tissue regeneration and other medical uses, demonstrating his ability to bridge molecular biology, biotechnology, and material science. His interdisciplinary work continues to advance the potential of silkworms in producing bio-functional materials with wide-ranging biomedical applications.

Publications and Achievements:

Feng Wang has authored and co-authored numerous high-impact publications in renowned scientific journals. His work spans diverse topics, with a particular focus on genetic engineering, biomaterials, and recombinant protein production. Notable recent publications include articles in Advanced Materials, Biomaterials, and Insect Science, with research exploring the production of functional silk fibroin-based biomaterials and the application of transgenic silkworms for large-scale recombinant protein production. Wang has contributed significantly to advancements in silk engineering, including the fabrication of silk sericin hydrogels for tissue repair and the development of silk-based systems for the delivery of therapeutic proteins. His collaborative approach has also led to joint publications with international researchers, further expanding the impact of his research. Wang’s scientific contributions have received global recognition, and his work continues to inspire advancements in bioengineering and biotechnology. He is also an active member of various research networks and collaborations, facilitating the exchange of knowledge and ideas across the global scientific community. With a growing body of work, his research continues to address pressing challenges in biomedical applications, making him a recognized leader in his field.

Strengths for the Award:

Feng Wang’s research is highly innovative and interdisciplinary, merging molecular biology, genetic engineering, and biomaterial science to address key challenges in biomedical applications. His expertise in genome editing, especially in transgenic silkworms, positions him as a leading figure in the development of functional biomaterials for medical use. Wang’s ability to apply cutting-edge techniques such as CRISPR/Cas9, TALEN, and ZFN for silkworm genetic modification has resulted in the creation of valuable materials, including recombinant pharmaceutical proteins and tissue-engineering scaffolds. His work in engineering silkworm spun silk to express functional proteins demonstrates both creativity and technical proficiency, allowing for the large-scale production of bio-functional biomaterials with significant medical potential. Wang’s leadership as an academic researcher and his extensive publication record, including high-impact journals with broad citations, further demonstrate his research excellence. His collaborative approach with both domestic and international research communities enhances the relevance and impact of his contributions. Overall, his continuous pursuit of innovative solutions for biomedical applications underscores his potential as a strong contender for the Best Researcher Award.

Areas for Improvement:

While Feng Wang has made significant contributions to his field, there are areas where his work can be further expanded to maximize its impact. One potential area for improvement is broadening the scope of his research to include more diverse applications of genetically modified silkworms, particularly in the context of personalized medicine or other innovative therapeutic strategies. Although Wang has focused heavily on protein production and tissue regeneration, there is room for exploring the potential of silkworm-based materials in other areas of biomedical engineering, such as drug delivery systems or diagnostic devices. Additionally, Wang could collaborate with industry partners to translate his findings into real-world applications more effectively. Strengthening his involvement in translational research could accelerate the commercialization of his discoveries, ensuring that his contributions have tangible benefits for society. Another area for improvement lies in the scalability and cost-efficiency of producing genetically modified silkworms and recombinant proteins, which could enhance the practicality and accessibility of his research outcomes. By addressing these challenges, Wang could further elevate the impact of his work and expand its application to broader sectors of healthcare.

Conclusion:

Feng Wang’s exceptional work in gene expression regulation, genome modification, and biomaterials development has significantly advanced the field of biotechnology, particularly in the context of biomedical applications. His pioneering research in genetically engineered silkworms has led to the creation of bio-functional silks that can be used in tissue engineering and the production of therapeutic proteins. With a proven track record of high-impact publications, international collaborations, and continuous innovation, Wang is a leading figure in his field. While there are areas where his research can expand, particularly in translating his findings into commercial applications and exploring additional biomedical uses for silkworm-derived materials, his contributions to science and technology are already substantial. Wang’s dedication to solving complex problems in biomedical engineering, combined with his technical expertise and visionary research, makes him a deserving candidate for the Best Researcher Award. His continued success and impact on the scientific community are promising, and his future work holds even greater potential for advancing healthcare technologies.

Publication Top Notes

1. Title: Fabrication of a transforming growth factor β1 functionalized silk sericin hydrogel through genetical engineering to repair alveolar bone defects in rabbit
   • Authors: Wang, F., Ning, A., Sun, X., Ma, X., Xia, Q.
   • Year: 2025
2. Title: Highly efficient expression of human extracellular superoxide dismutase (rhEcSOD) with ultraviolet-B-induced damage-resistance activity in transgenic silkworm cocoons
   • Authors: Wang, F., Wang, R., Zhong, D., Zhao, P., Xia, Q.
   • Year: 2024
   • Citations: 5
3. Title: CRISPR/Cas9-Mediated Editing of BmEcKL1 Gene Sequence Affected Silk Gland Development of Silkworms (Bombyx mori)
   • Authors: Li, S., Lao, J., Sun, Y., Zhao, P., Xia, Q.
   • Year: 2024
   • Citations: 5
4. Title: Antimicrobial mechanism of Limosilactobacillus fermentum SHY10 metabolites against pickle film-producing strain by metabolomic and transcriptomic analysis
   • Authors: Lian, Y., Luo, S., Song, J., Liu, K., Zhang, Y.
   • Year: 2024
5. Title: An Efficient Biosynthetic System for Developing Functional Silk Fibroin-Based Biomaterials
   • Authors: Wang, F., Lei, H., Tian, C., Kaplan, D.L., Xia, Q.
   • Year: 2024
6. Title: The different effects of molybdate on Hg(II) bio-methylation in aerobic and anaerobic bacteria
   • Authors: Wang, L., Liu, H., Wang, F., Wang, D., Shen, H.
   • Year: 2024
   • Citations: 1
7. Title: Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition
   • Authors: Liu, W., Ji, Y., Wang, F., Liu, Y., Cui, H.
   • Year: 2023
   • Citations: 3
8. Title: Correction: Optimization of a 2A self-cleaving peptide-based multigene expression system for efficient expression of upstream and downstream genes in silkworm
   • Authors: Wang, Y., Wang, F., Xu, S., Zhao, P., Xia, Q.
   • Year: 2023